Brian Abrahams
Recent Articles
Pharma's Flu Drug Could Be Worth Billions, Analyst Says 09/29/2025
Cidara Therapeutics Inc. (CDTX:NASDAQ) shares the minutes from an important meeting with the FDA, and the overall feedback was encouraging. Find out what one analyst predicts that will mean for Phase III development.
Due to permission requirements, not all quotes are shown.
